Action of Ukrain, a cytostatic and immunomodulating drug, on effects of irradiation

Drugs under Experimental and Clinical Research

Volumn 22, Issue 3-5, 1996, Pages 167-171

  Boyko, V N ^a   Voltchek, I V ^b   Petrov, A S ^a   Bubnov, V P ^a  

^a Ministry of Defense of the Russian Federation   (Russian Federation)

^b Avalanche Joint Stock Company   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID; UKRAIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOSTASIS; DRUG EFFECT; IMMUNOMODULATION; INTRAPERITONEAL DRUG ADMINISTRATION; IRRADIATION; MALE; MOUSE; NONHUMAN; RADIATION DOSE; SURVIVAL RATE; TIME; TREATMENT OUTCOME;

ADJUVANTS, IMMUNOLOGIC; ALKALOIDS; ANIMALS; ANTINEOPLASTIC AGENTS; BERBERINE ALKALOIDS; MALE; MICE; MICE, INBRED CBA; PHENANTHRIDINES; WHOLE-BODY IRRADIATION;

EID: 0029791319     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Nowicky J.W. Biological properties of Ukrain in experimental and clinical investigations. Int. Med. Rev., 1, 5-10, 1993.
2. Nowicky J.W., Manolakis G., Meijer D., Vatanasapt V., Brzosko W.J. Ukrain both as an anticancer and immunoregulatory agent. Drugs Exptl. Clin. Res., XVIII (Suppl.), 51-54, 1992.
3. Krasilnikov I.I., Zhakovko E.B., Chigareva N.G. Experimental study of radioprotective efficacy of vinca alkaloid drugs. Radiobiol. Radioecol., 34, 430-435, 1994.
4. Goncharenko E.N., Kudryashov Y.B. Anti-radiation drugs from natural sources. Radiobiologia, 111, 302-316, 1991. (In Russian)
5. Kurishita A. et al. Postirradiation treatment with OK432 can prevent radiation-induced bone marrow death. Int. J. Radiat. Biol., 59, 711-716, 1991.
6. Boyko V.N. On radioprotective efficacy of chemiopreparations. In: Proceedings of the All-Russian Conference "Prikladnyie aspekty radiobiologii", Moscow, April 19-20 1994, p. 27. (In Russian)
7. Vladimirov V.G., Poddubsky G.A., Razorionov G.I. "Radioprotective prescriptions". Voenizdat, Leningrad, 1988, p. 144. (In Russian)
8. Vladimirov V.G., Krasilnikov I.I., Arapov O.V. "Radioprotectors: structure and functions". Navukova Dumka, Kiev, 1989, p. 264.
9. Bruller W. Studies concerning the effect of Ukrain in vivo and in vitro. Drugs Exptl. Clin. Res., XVIII (Suppl.), 13-16, 1992.
10. Hosek B., Misustova J., Zejekand A., Kautska J. Resistance to prolonged irradiation in mice influenced by thyroid hormones and chemical radiation protectors. Acta Radiologica Oncology, 21, 115-120, 1982.
11. Legeza V.I. et al. The effect of riboxine on resistance of mice to prolonged irradiation at non-lethal doses. Radiatsyonnaya Biologiya, Radioekologiya, 33, 658-664, 1993. (In Russian)
12. Boyko V.N., Shadrin O.V., Derevianchenko I.G., Buntsevicti A.M., Bykovskaya S.N. Radioprotective effect of a compound preparation of cytokine - lymphokinine. Bull. Exper. Biol. Med., 118, 38-40, 1994. (In Russian)
13. Boyko V.N. Studies on antiradiation efficacy of biologically active preparations under different conditions of irradiation. Theses of Radiobiological Congress. Puschino, 1993, pp. 123-124. (In Russian)
14. Gallicchio V.S. et al. Basic fibroblast growth factor (B-FGF) stimulates the proliferation of uncommitted and committed hematopoietic progenitors and is radioprotective in vitro. Exp. Hematol, 17, 578,1989.
15. MacVittie T.J. et al. Rescue of lethally irradiated canines using therapeutic administration of either recombinant G-CSF (rhG-CSF) or GM-CSF (rhGM-CSF). Exp. Hematol., 17, 579, 1989.